196 results on '"Fiebelkorn, Amy Parker"'
Search Results
2. Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2020
3. The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021—December 2022
4. Influenza Vaccination Coverage Among Health Care Personnel — United States, 2017–18 Influenza Season
5. Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2018
6. Progress in Childhood Vaccination Data in Immunization Information Systems — United States, 2013–2016
7. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine
8. Influenza Vaccination Coverage Among Pregnant Women — United States, 2016–17 Influenza Season
9. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2015
10. Awareness among adults of vaccine-preventable diseases and recommended vaccinations, United States, 2015
11. Trends in compliance with two-dose influenza vaccine recommendations in children aged 6 months through 8 years, 2010–2015
12. Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults
13. Measles in Healthcare Facilities in the United States During the Postelimination Era, 2001–2014
14. Measles — United States, January 4–April 2, 2015
15. A global perspective of vaccination of healthcare personnel against measles: Systematic review
16. Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network--United States, March 2021
17. Measles — United States, January 1–May 23, 2014
18. Mumps
19. Readiness to Vaccinate Critical Personnel During an Influenza Pandemic, United States, 2015
20. Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 : Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
21. A Comparison of Postelimination Measles Epidemiology in the United States, 2009–2014 Versus 2001–2008
22. Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era
23. Immunization of Health-Care Personnel : Recommendations of the Advisory Committee on Immunization Practices (ACIP)
24. Measles in the United States during the Postelimination Era
25. Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine
26. Influenza Vaccination in Health Centers during the COVID-19 Pandemic—United States, November 7–27, 2020
27. Influenza Vaccination in Health Centers During the Coronavirus Disease 2019 Pandemic—United States, 7–27 November 2020
28. Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA
29. Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad.
30. List of Contributors
31. Measles vaccine
32. Environmental factors potentially associated with mumps transmission in Yeshivas during a mumps outbreak among highly vaccinated students Brooklyn, New York, 2009-2010
33. Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine
34. Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers
35. Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017–2018
36. Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations among Women With a Live Birth, Internet Panel Survey, 2017-2018
37. Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.
38. The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad
39. The Clinical Impact and Cost-effectiveness of Measles-Mumps-Rubella Vaccination to Prevent Measles Importations Among International Travelers From the United States
40. U.S. clinicians’ and pharmacists’ reported barriers to implementation of the Standards for Adult Immunization Practice
41. Characteristics of Large Mumps Outbreaks in the United States, July 2010–December 2015
42. Information for CME Credit—Clinicians’ and Pharmacists’ Reported Implementation of Vaccination Practices for Adults
43. Key Elements for Conducting Vaccination Exercises for Pandemic Influenza Preparedness
44. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults
45. Clinicians’ and Pharmacists’ Reported Implementation of Vaccination Practices for Adults
46. Three Cases of Congenital Rubella Syndrome in the Postelimination Era — Maryland, Alabama, and Illinois, 2012
47. Assessment of the Status of Measles Elimination in the United States, 2001–2014
48. Tdap and Influenza Vaccination Among Women with a Live Birth, Internet Panel Survey, United States, 2015–2016
49. Measles, Mumps, and Rubella Antibody: Patterns of Persistence and Rate of Decline Following the Second Dose of the MMR Vaccine
50. Measles in Healthcare Facilities in the United States during the Post-elimination Era, 2001- 2014
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.